Jeffrey J. Abrams serves as Executive at Imprimis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey J. Abrams has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 27, 2013 involved receiving (via award) 6,865 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 27, 2013 | IMMY | $0 | Award | 6,865 | $N/A | Discretionary |
Jeffrey J. Abrams currently holds 45,927 shares of Imprimis Pharmaceuticals, Inc. (IMMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey J. Abrams has been a net neutral trader of IMMY stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey J. Abrams's most recent insider trade was on Jun 27, 2013, when they sold 6,865 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted